Share Wealth

Market
  • Markets Navigation
    Company Info.

    Ganga Pharmaceuticals Ltd.

    Shareholding Pattern


    Market Cap.(`) 9.01 Cr. P/BV 1.40 Book Value (`) 13.30
    52 Week High/Low ( ` ) 28/15 FV/ML 10/8000 P/E(X) 193.96
    Book Closure 25/09/2024 EPS (`) 0.10 Div Yield (%) 0.00
    You can view the shareholding pattern for the latest two quarters for the company under two broad categories (Promoter & Non Promters).

    •  

    Shareholding Pattern as on 30/09/2024
    Summary statement holding of specified securities
    Category of shareholder Nos. of shareholders No. of fully paid up equity shares held Total nos. shares held Shareholding as a % of total no. of shares (calculated as per SCRR, 1957)As a % of (A+B+C2) No. of shares underlying outstanding convertible securities (including warrants) Shareholding as a % assuming full conversion of convertible securities (as a percentage of diluted share capital) As a % of (A+B+C2) No. of Locked in shares - No.(a) No. of Locked in shares - As a % of total shares held(b) Number of equity shares held in dematerialized form
    (A) Promoter & Promoter Group 8 2709550 2709550 56.02 1000000 56.11 0 0.00 2709550
    (B) Public 357 2126950 2126950 43.98 775000 43.89 775000 36.44 1936100
    (C1) Shares underlying DRs 0 0 0 0.00 0 0.00 0 0.00 0
    (C2) Shares held by Employee Trust 0 0 0 0.00 0 0.00 0 0.00 0
    (C) Non Promoter-Non Public 0 0 0 0.00 0 0.00 0 0.00 0
    Grand Total 365 4836500 4836500 100.00 1775000 100.00 775000 16.02 4645650

    Category of shareholder Nos. of shareholders No. of fully paid up equity shares held No. of shares underlying Depository Receipts Total nos. shares held Shareholding as a % of total no. of shares (calculated as per SCRR, 1957)As a % of (A+B+C2) Number of equity shares held in dematerialized form
    Shareholding of Promoter and Promoter Group
    Indian
    Individuals / Hindu Undivided Family 8 2709550 0 2709550 56.02 2709550
    SHARMA BHARAT B 1 1456585 0 1456585 30.12 1456585
    BRIJMOHAN SHARMA HUF 1 349500 0 349500 7.23 349500
    ANAGH BHARAT SHARMA 1 260000 0 260000 5.38 260000
    SRIJNA SHARMA 1 241905 0 241905 5.00 241905
    BHARAT BRIJMOHAN SHARMA HUF SHARMA 1 190000 0 190000 3.93 190000
    USHA SHUKLA 1 95110 0 95110 1.97 95110
    AMIT SHUKLA 1 76450 0 76450 1.58 76450
    ANKITA AMIT SHUKLA 1 40000 0 40000 0.83 40000
    Grand Total827095500270955056.022709550
    Public Shareholding
    Non-Institutions
    Any Others (Specify) 3 16000 0 16000 0.33 16000
    HUF 2 16000 0 16000 0.33 0
    LLP 1 0 0 0 0.00 0
    Bodies Corporate 2 399000 0 399000 8.25 399000
    LENUS FINVEST PRIVATE LIMITED 1 375000 0 375000 7.75 375000
    Resident Individuals holding nominal share capital up to Rs. 2 lakhs 332 607950 0 607950 12.57 417100
    Resident Individuals holding nominal share capital in excess of Rs. 2 lakhs 19 1096000 0 1096000 22.66 1096000
    PRAKASH DHIRAJLAL TANNA 1 325000 0 325000 6.72 0
    MR. NIRANJAN KUMAR GOEL 1 144000 0 144000 2.98 0
    AKSHAY AMARNATH SHARMA 1 72000 0 72000 1.49 0
    SANJAY DHANSUKHLAL SHAH 1 72000 0 72000 1.49 0
    VAIBHAVIBEN NITINKUMAR AKHANI 1 50000 0 50000 1.03 0
    Non Resident Indians (NRIs) 1 8000 0 8000 0.17 8000
    Sub Total35721269500212695043.981936100
    Grand Total35721269500212695043.981936100

  • Ganga Pharmaceuticals Ltd.

    Products & Raw Material


    Market Cap.(`) 9.01 Cr. P/BV 1.40 Book Value (`) 13.30
    52 Week High/Low ( ` ) 28/15 FV/ML 10/8000 P/E(X) 193.96
    Book Closure 25/09/2024 EPS (`) 0.10 Div Yield (%) 0.00

    You can view the entire product & raw materials mix with Product names, Sales quantity & Value along with percentage contribution from each individual product.

    Product Report
    Product NameYearMonthSales QuantityUOMSales Value (` Crs.)Product Mix (%)
    Pharmaceuticals2024120.00-2.74100.00
    Raw Material Report
    Product NameYear/MonthSales QuantityUOMSales Value (` Crs)Product Mix (%)
    Raw Materials24/030.00Not Reported1.32100.00
Attention Investors : “Prevent unauthorized transactions in your account ? Update your Mobile Numbers/Email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your Mobile/Email at the end of the day. Issued in the interest of Investors” ***** No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.   |     |  ***** KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.   |  "Revised guidelines on margin collection ==> 1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. | 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. | 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. | 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. | 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. .......... Issued in the interest of Investors"   |  ***** MEMBERS : SEBI Regn. No: NSE, BSE: INZ000176636 ; MCX : INZ000057535; SEBI Research Analyst Regn No: INH200000337; AMFI Regn No. 77624; Depository Participant : CDSL : IN-DP-CDSL-379-2006 DP ID : 12047600   |  For any Grievance mail to : grievance@sharewealthindia.com   |  For any DP Grievance mail to : dpgrievance@sharewealthindia.com.   |  Grievance with SEBI : https://scores.gov.in/scores/Welcome.html